Ionis Pharmaceuticals Inc IONS
Insiders bought $1.2M and sold $19.7M on the market
Form 4Open-market buys and sales are the trades an insider chose to make. Grants, option exercises and shares withheld for tax are pay; they show under All.
A year of insider trades, day by day
Open-market buys and sales by officers and directors · Form 4, since Nov 24, 2025
$1.2M bought on 3 days, $19.7M sold on 9 days. Each square is a day; click one for its Form 4.
Buys and sales by insider
Who traded · Form 4, added up
| Insider | Bought | Sold | Latest |
|---|---|---|---|
| Brett P. Monia Chief Executive Officer, Director |
- | $6.8M | Jun 26, 2026 |
| Holly B. Kordasiewicz EVP, Chief Development Officer |
- | $4.5M | Jul 7, 2026 |
| Eugene Schneider EVP, Chf Clinical Develop Ofcr |
- | $2.1M | Jun 26, 2026 |
| C. Frank Bennett EVP, Chief Scientific Officer |
- | $1.7M | Jul 7, 2026 |
| Michael R. Hayden Director |
$1.2M | - | Nov 10, 2026 |
| Spencer R. Berthelsen Director |
- | $1.2M | Jun 15, 2026 |
| Joseph Klein III Director |
- | $910K | Jul 1, 2026 |
| Allene M. Diaz Director |
- | $864K | Jul 7, 2026 |
| Eric Swayze EVP Research |
- | $842K | Oct 16, 2026 |
| Joseph Baroldi EVP, Chief Business Officer |
- | $452K | Jun 26, 2026 |
| Patrick R. O'Neil EVP CLO & General Counsel |
- | $246K | Jun 26, 2026 |
| Shannon L. Devers EVP, Chief Human Resources Ofc |
- | $59K | Oct 16, 2026 |
Owned after: shares held right after the person's latest buy or sale, from the Form 4 the date links to. % of shares: that holding over the shares outstanding on the latest cover page. Only people who bought or sold in this period are listed, and options, restricted units and shares held by others are not counted, so the rows are not a total of what insiders own.
Trade by trade, newest first
Every trade · each date links to its Form 4
Of 19 open-market sales by officers and directors, 8 came in the 30 days before a 10-Q, a 10-K or a results 8-K. Of 3 buys, 0. Dates only, from the filing index; most companies close the window for insider trades in the weeks before results, so a trade there is often under a 10b5-1 plan.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Nov 10, 2026 | Michael R. Hayden (indirect) | Buy | 5,000 | 148K |
| Oct 16, 2026 | Eric Swayze (indirect) | Sale | -53 | 2K |
| Oct 16, 2026 | Shannon L. Devers | Sale | -1,357 | 59K |
| Jul 31, 2026 | Michael R. Hayden (indirect) | Buy | 5,000 | 258K |
| Jul 30, 2026 | Michael R. Hayden (indirect) | Buy | 15,000 | 801K |
| Jul 7, 2026 | Holly B. Kordasiewicz | Sale (10b5-1) | -362 | 31K |
| Jul 7, 2026 | Allene M. Diaz | Sale (10b5-1) | -10,111 | 864K |
| Jul 7, 2026 | C. Frank Bennett | Sale (10b5-1) | -5,536 | 463K |
| Jul 7, 2026 | C. Frank Bennett (indirect) | Sale (10b5-1) | -15,000 | 1.3M |
| Jul 1, 2026 | Joseph Klein III | Sale (10b5-1) | -99 | 8K |
| Jul 1, 2026 | Joseph Klein III | Sale (10b5-1) | -11,419 | 903K |
| Jun 26, 2026 | Brett P. Monia | Sale (10b5-1) | -50,000 | 4.0M |
| Jun 26, 2026 | Eugene Schneider | Sale (10b5-1) | -26,000 | 2.1M |
| Jun 26, 2026 | Patrick R. O'Neil | Sale (10b5-1) | -3,069 | 246K |
| Jun 26, 2026 | Joseph Baroldi (indirect) | Sale (10b5-1) | -5,635 | 452K |
| Jun 25, 2026 | Eric Swayze | Sale (10b5-1) | -10,602 | 839K |
| Jun 25, 2026 | Brett P. Monia | Sale (10b5-1) | -21,072 | 1.7M |
| Jun 24, 2026 | Brett P. Monia | Sale (10b5-1) | -14,565 | 1.1M |
| Jun 15, 2026 | Spencer R. Berthelsen | Sale (10b5-1) | -8,000 | 588K |
| Jun 12, 2026 | Holly B. Kordasiewicz | Sale (10b5-1) | -41,004 | 3.0M |
| Jun 12, 2026 | Holly B. Kordasiewicz | Sale (10b5-1) | -19,842 | 1.5M |
| Jun 1, 2026 | Spencer R. Berthelsen | Sale (10b5-1) | -8,000 | 605K |
Show the other 7 trades
Sources
Form 4s from SEC's filing index. An insider files one within two business days of a trade.
Also
Insider selling plans: the 10b5-1 plans and Form 144 notices behind planned sales.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/IONS/export.csv") into a cell.